• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Thorac Dis . Establishment and evaluation of a 30-minute detection method for SARS-CoV-2 nucleic acid using a novel ultra-fast real-time PCR inst

tetano

Editor, Senior Moderator
J Thorac Dis


. 2021 Dec;13(12):6866-6875.
doi: 10.21037/jtd-21-1288.
Establishment and evaluation of a 30-minute detection method for SARS-CoV-2 nucleic acid using a novel ultra-fast real-time PCR instrument


Wenkuan Liu[SUP] #[/SUP][SUP] 1 [/SUP], Zhichao Zhou[SUP] #[/SUP][SUP] 1 [/SUP], Lu Zhang[SUP] #[/SUP][SUP] 2 [/SUP], Lei Li[SUP] 3 [/SUP], Lin Wang[SUP] 4 [/SUP], Linxiu Song[SUP] 4 [/SUP], Shuyan Qiu[SUP] 1 [/SUP], Li Zhang[SUP] 1 [/SUP], Duo Xu[SUP] 1 2 3 4 5 [/SUP], Xingui Tian[SUP] 1 [/SUP], Xiao Li[SUP] 1 [/SUP], Yujie Yang[SUP] 1 [/SUP], Jiaxin Liang[SUP] 1 [/SUP], Yong Liu[SUP] 4 [/SUP], Xiaobo Li[SUP] 2 [/SUP], Rong Zhou[SUP] 1 5 [/SUP]



Affiliations
Free PMC article

Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic is still raging worldwide. Efficient, fast and low-cost severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid detection methods are urgently needed.
Methods: A rapid PCR temperature change mode was explored by moving the reaction tube between the independent temperature modules with large temperature differences and a portable ultra-fast real-time PCR instrument were developed. We established a rapid SARS-CoV-2 test method using the ultra-fast real-time PCR instrument, a China Food and Drug Administration-certified SARS-CoV-2 reagent and optimized reaction condition. The analytical and clinical performances of the rapid tests were evaluated by comparing with the standard SARS-CoV-2 tests.
Results: The new temperature change mode can effectively shorten the amplification reaction time and be successfully used in the development of the ultra-fast real-time PCR instrument. The rapid SARS-CoV-2 test method was established and the time to yield results were greatly shortened from 81 min of the standard test to 31 min. Specificity of the rapid test was assessed and no non-specific amplification (0/63) was observed. The limits of detection of the rapid and standard tests were similar. Clinical performance was evaluated using 184 respiratory specimens from patients with suspected SARS-CoV-2 infection. The positive agreement between the rapid and standard tests was 100% (67/67), the negative agreement was 97.4% (114/117), and the kappa statistic was 0.965 (P<0.001). No significant differences in the Ct values for each target gene were observed between the rapid test and the standard test (P>0.05).
Conclusions: We had developed a 30-minute detection method for SARS-CoV-2 nucleic acid using a novel ultra-fast real-time PCR instrument. The rapid test method may impact on patient management.

Keywords: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); coronavirus disease 2019 (COVID-19); pandemic prevention and control; rapid test; ultra-fast real-time PCR instrument.
 
Back
Top Bottom